Advertisement

Ads Placeholder
Loading...

PureTech Health plc

PTCHF•PNK
Healthcare
Biotechnology
$1.56
$0.01(0.65%)
U.S. Market opens in 3h 36m

PureTech Health plc (PTCHF) Stock Overview

Explore PureTech Health plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap379.7M
P/E Ratio7.77
EPS (TTM)$0.17
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$1.42
3 Months$1.68
1 Year Target$1.35

PTCHF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of PureTech Health plc (PTCHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 21.70, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $1.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 7.77 and a market capitalization of 379.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.65%
5-Day Change
0.65%
1-Month Change
-2.50%
3-Month Change
-8.24%
6-Month Change
-17.89%
Year-to-Date (YTD) Change
-8.77%
1-Year Change
2.63%
3-Year Change
-42.86%
5-Year Change
-73.33%
All-Time (Max) Change
-34.73%

Contact Information

https://www.puretechhealth.com
617 482 2333
6 Tide Street, Boston, MA, 02210

Company Facts

800 Employees
IPO DateJul 29, 2015
CountryUS
Actively Trading

Frequently Asked Questions